Espinoza Octavio bought LGND
March 4, 2026 · Form 4 insider transaction
Espinoza Octavio bought 466 shares of Ligand Pharmaceuticals Incorporated at $80.72 per share, a transaction worth $37.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
466
Price
$80.72
Total value
$37.6K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 4, 2026
Filing dateMarch 6, 2026
Shares owned after35,085
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1.